Self‐Enhancing Drug Pair‐Driven Selenium Nanotherapeutics Reverses Microglial Pyroptosis Through NLRP3/Caspase‐1 Pathway and Neuronal Apoptosis for Treatment of Spinal Cord Injury
Source abstract
Abstract
Abstract Spinal cord injury (SCI) constitutes a critical occurrence that results in the disruption of both motor and sensory functions. Oxidative stress‐induced apoptosis and pyroptosis have been identified as critical contributors to neuronal damage during the secondary injury phase following SCI. Therefore, this study focuses on the development of self‐enhancing drug pair‐driven selenium (Se) nanotherapeutics, loading with 2,3,5,6‐tetramethylpyrazine (TMP) and Ginsenoside Rg1 (Rg1), to enhance the treatment of SCI. The engineered LET/TMP/Rg1@Se NPs exhibits remarkable antioxidant properties, effectively reducing oxidative stress‐induced neuronal injury by minimizing reactive oxygen species (ROS) accumulation and restoring mitochondrial function. In addition to their antioxidant effects, this nanotherapeutics demonstrates significant anti‐pyroptotic effects in BV2 microglial cells by modulating the NLRP3/caspase‐1 pathway, leading to the decreased release of pro‐inflammatory cytokines IL‐1β and IL‐18. Moreover, this inhibition of inflammatory cascade response diminishes the neuroinflammation‐induced neuronal apoptosis and promotes axonal regeneration of neurons in vitro. In a mouse model of SCI, treatment with LET/TMP/Rg1@Se NPs results in improved motor function and axonal regeneration, attributed to the inhibition of apoptosis and pyroptosis, highlighting the scientific basis for the synergistic self‐enhancing effect of drug pair‐driven Se nanotherapeutics as an innovative strategy for effective SCI therapy.
Source: crossref · Quality: baseline
Research context
OpenAlex topics: Inflammasome and immune disorders · Heme Oxygenase-1 and Carbon Monoxide · Spinal Cord Injury Research
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
Affiliations
State Key Laboratory of Traditional Chinese Medicine Syndrome The Second Clinical Medical College of Guangzhou University of Chinese Medicine Guangzhou University of Chinese Medicine Guangzhou 510120 China
Orthopedics Department Guangdong Provincial Hospital of Chinese Medicine Guangzhou 510120 China
Department of Chemistry Jinan University Guangzhou 510632 China
Funding
National Key Research and Development Program of China · National Natural Science Foundation of China
References (74)
Show source-provided references
1. 10.1126/science.adi641210.1126/science.adi6412 ↗
2. 10.1038/s41586-024-07504-y10.1038/s41586-024-07504-y ↗
3. 10.1002/adfm.20240795810.1002/adfm.202407958 ↗
4. 10.1038/s41593-022-01196-110.1038/s41593-022-01196-1 ↗
5. 10.1038/s41591-019-0475-610.1038/s41591-019-0475-6 ↗
6. 10.1016/S1474-4422(20)30406-310.1016/S1474-4422(20)30406-3 ↗
7. 10.1038/s41582-019-0280-310.1038/s41582-019-0280-3 ↗
8. 10.1002/adfm.20240456310.1002/adfm.202404563 ↗
9. 10.1002/adfm.20240390010.1002/adfm.202403900 ↗
10. 10.1016/j.biomaterials.2023.12235810.1016/j.biomaterials.2023.122358 ↗
11. 10.1016/j.nantod.2024.10222910.1016/j.nantod.2024.102229 ↗
12. 10.1002/advs.20230464810.1002/advs.202304648 ↗
13. 10.1002/adfm.20221287010.1002/adfm.202212870 ↗
14. 10.1038/nature1862910.1038/nature18629 ↗
15. 10.1002/adma.20231324810.1002/adma.202313248 ↗
16. 10.1038/s41577-019-0228-210.1038/s41577-019-0228-2 ↗
17. 10.1016/j.ebiom.2018.12.05910.1016/j.ebiom.2018.12.059 ↗
18. 10.1038/s41467-022-28787-710.1038/s41467-022-28787-7 ↗
19. 10.1021/acsnano.3c0036010.1021/acsnano.3c00360 ↗
20. 10.1021/acsnano.3c0804610.1021/acsnano.3c08046 ↗
21. 10.4103/1673-5374.31798910.4103/1673-5374.317989 ↗
22. 10.1186/s12951-022-01490-x10.1186/s12951-022-01490-x ↗
23. 10.1016/j.jconrel.2021.05.01610.1016/j.jconrel.2021.05.016 ↗
24. 10.1039/D3TB02160B10.1039/D3TB02160B ↗
25. 10.1016/j.ejphar.2024.17671010.1016/j.ejphar.2024.176710 ↗
26. 10.1016/j.bmcl.2016.01.01510.1016/j.bmcl.2016.01.015 ↗
27. 10.1039/C8TB02520G10.1039/C8TB02520G ↗
28. 10.1016/j.biopha.2017.07.16210.1016/j.biopha.2017.07.162 ↗
29. 10.1155/2022/223236510.1155/2022/2232365 ↗
30. 10.1016/j.biopha.2022.11320710.1016/j.biopha.2022.113207 ↗
31. 10.1021/acs.jafc.4c0127110.1021/acs.jafc.4c01271 ↗
32. 10.1016/j.phymed.2023.15523810.1016/j.phymed.2023.155238 ↗
33. 10.1016/j.jep.2024.11853110.1016/j.jep.2024.118531 ↗
34. 10.1016/j.lfs.2020.11764210.1016/j.lfs.2020.117642 ↗
35. 10.1016/j.bioactmat.2024.03.03410.1016/j.bioactmat.2024.03.034 ↗
36. 10.1016/j.drup.2024.10110210.1016/j.drup.2024.101102 ↗
37. 10.1002/adma.20240162010.1002/adma.202401620 ↗
38. 10.1002/advs.20240391810.1002/advs.202403918 ↗
39. 10.1002/advs.20230088010.1002/advs.202300880 ↗
40. 10.1016/j.redox.2020.10151910.1016/j.redox.2020.101519 ↗
41. 10.1177/0963689722110988410.1177/09636897221109884 ↗
42. 10.1186/s12951-024-02302-010.1186/s12951-024-02302-0 ↗
43. 10.1021/acsami.4c1245410.1021/acsami.4c12454 ↗
44. 10.1002/adfm.20240126410.1002/adfm.202401264 ↗
45. 10.1038/s41420-024-02278-810.1038/s41420-024-02278-8 ↗
46. 10.1016/j.bioactmat.2022.11.00110.1016/j.bioactmat.2022.11.001 ↗
47. 10.1016/j.ijbiomac.2021.10.18910.1016/j.ijbiomac.2021.10.189 ↗
48. 10.1039/C6CS00636A10.1039/C6CS00636A ↗
49. 10.1021/acs.accounts.3c0012210.1021/acs.accounts.3c00122 ↗
50. 10.1038/s41565-021-00858-810.1038/s41565-021-00858-8 ↗
51. 10.1021/acs.jafc.3c0440610.1021/acs.jafc.3c04406 ↗
52. 10.1002/jnr.2522110.1002/jnr.25221 ↗
53. 10.1021/acsmaterialslett.3c0112610.1021/acsmaterialslett.3c01126 ↗
54. 10.1002/advs.20240722510.1002/advs.202407225 ↗
55. 10.1016/j.bioactmat.2022.04.02910.1016/j.bioactmat.2022.04.029 ↗
56. 10.1016/j.apsb.2023.07.01010.1016/j.apsb.2023.07.010 ↗
57. 10.1186/s12951-024-03054-710.1186/s12951-024-03054-7 ↗
58. 10.1002/advs.20230212310.1002/advs.202302123 ↗
59. 10.1021/acs.jpcb.2c0127110.1021/acs.jpcb.2c01271 ↗
60. 10.1002/adma.20220857110.1002/adma.202208571 ↗
61. 10.1021/acschemneuro.3c0059610.1021/acschemneuro.3c00596 ↗
62. 10.1186/s40779-022-00404-010.1186/s40779-022-00404-0 ↗
63. 10.1038/s41419-023-06327-510.1038/s41419-023-06327-5 ↗
64. 10.3390/ijms2013332810.3390/ijms20133328 ↗
65. 10.1016/j.intimp.2018.12.01910.1016/j.intimp.2018.12.019 ↗
66. 10.1038/s41392-023-01588-010.1038/s41392-023-01588-0 ↗
67. 10.1038/s41586-024-07167-910.1038/s41586-024-07167-9 ↗
68. 10.1038/s41565-023-01416-010.1038/s41565-023-01416-0 ↗
69. 10.1002/adhm.20230426110.1002/adhm.202304261 ↗
70. 10.1021/acsnano.9b0759810.1021/acsnano.9b07598 ↗
71. 10.1016/j.cej.2023.14412110.1016/j.cej.2023.144121 ↗
72. 10.1002/advs.20230899310.1002/advs.202308993 ↗
73. 10.1002/adhm.20220237710.1002/adhm.202202377 ↗
74. 10.1126/sciadv.adj426010.1126/sciadv.adj4260 ↗